BLOG
Blog
Pragmatic Approaches to Assessing Physical Withdrawal in Clinical Trials
Explore pragmatic strategies for assessing physical withdrawal in clinical trials, including study design challenges, measurement tools, and patient-centric solutions.
Blog
Shaping the Future of Microsampling at Altasciences by Jeff Plomley
Jeff Plomley discusses how patient-centric blood microsampling can enable at-home, minimally invasive sample collection, and improve accessibility and clinical trial efficiency.
Blog
The Efficacy of Fear: How Clinical Trials Gave Me Life | Michelle Newby
Explore the patient experience in clinical trials through one survivor’s story, and how clinical research transformed her life after a leukemia diagnosis.
Blog
JAK1-siRNA Treatment for Inflammatory Skin Diseases: Real-World Nonclinical Insights
Nonclinical study of JAK1-siRNA in minipigs shows targeted, long-lasting efficacy for inflammatory skin diseases with minimal systemic exposure.
Blog
Navigating to the Clinic: Key Aspects of Translational Pharmacology, By Bruce Morimoto
Discover translational pharmacology strategies from industry expert to improve target validation, PK/PD understanding, and animal-to-human translation in early-phase drug development.
Blog
Why Women in STEM Matter More Than Ever: Shaping the Future of Science, by Kimberly Worley
Kimberly Worley shares her STEM journey, highlighting mentorship, diversity, and how empowering girls strengthens innovation and the future of science.
Blog
First-in-Human-Enabling Toxicology Programs: Common Misconceptions by Grace M. Furman
Grace Furman, President and CEO of Paracelsus, explores common misconceptions in IND-enabling toxicology programs and how sound regulatory toxicology supports safe, successful FIH trials.


